The HIF1-α antisense lncRNA (HIFAL) has been found to specifically upregulate HIF1-α activity in the glycolysis of breast cancer; however, further studies that focus on CRC are warranted [38]. This evidence concerns the gene HIF1A and breast carcinoma.